Package Insert: Information for the User
Hydrocortisone aceponate
Read this entire package insert carefully before starting to use this medication, as it contains important information for you.
It contains hydrocortisone aceponate as its active ingredient, which is a corticosteroid (anti-inflammatory), that when applied to the skin reduces redness, inflammation, and itching caused by certain skin problems.
Suniderma cream is indicated for skin conditions (dermatoses) that respond to treatment with corticosteroids, such as various types of eczema: skin rash due to allergy or substances that irritate the skin (allergic and irritant contact dermatitis), skin rash related to patient factors (atopic dermatitis), skin rash with inflammation and scaling (seborrheic dermatitis), itchy skin plaques caused by scratching (neurodermatitis), scaly, reddish skin condition often covered with silver scales (psoriasis).
Suniderma, in this pharmaceutical form, in cream, will be used particularly in acute and exudative forms (that secrete liquid).
Do not use Suniderma cream
Warnings and precautions
Consult your doctor or pharmacist before starting to use Suniderma cream.
Children and adolescents
In children, it is morelikely that the corticosteroid will pass through the skin and have adverse effects in other areas of the bodythan in adult patients.
It is preferable to avoid the use of corticosteroids in children and pay special attention to occlusions such as those produced by diapers.
Use of Suniderma cream with other medications
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or intend to become pregnant, consult your doctor before using this medication.
This medicationshould not be used during pregnancy,except if the benefit to the mother justifies the potential risk to the fetus.
As a general rule, duringthe first trimester of pregnancydo not applySuniderma cream.
Pregnant women or those planning to become pregnant should not apply it to large areas of the skin, or for prolonged periods, or use occlusive dressings.
If you are breastfeeding, inform your doctor before using Suniderma cream. If you use it during breastfeeding, do not apply the cream to the breast area.
Driving and operating machinery
Treatment with Suniderma does not affect the ability to drive or operate machinery.
Suniderma cream contains alcohol estearílico
This medicationmay cause local skin reactions (such as contact dermatitis) because it containsalcohol estearílico.
Suniderma cream contains 22 mg of benzyl alcohol per gram of cream.
Benzyl alcohol may cause allergic reactions and moderate local irritation.
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
-Adults: Apply 1 or 2 times a day. Apply a thin layer of cream directly to the affected area, massaging it in until fully absorbed.
Do not exceed 2 applications per day. Increasing the number of daily applications may worsen side effects without improving the therapeutic efficacy of the medication.
When improvement occurs, the application frequency may be reduced.
If the doctor considers it necessary, in chronic conditions, treatment may be prolonged for 2 weeks. Treatment should be intermittent (e.g., once a day, twice a week), with medical follow-up.
Use in children
The recommended dosage is 1 daily application.
Continuous use in children should not exceed 1 week, and the minimum effective amount of the product should be applied.
If the doctor considers it necessary to use for a prolonged period, treatment-free periods should be interposed.
Adhesive dressings (such as diapers) should be avoided in young children when using this medication.
Skin use.
Gently press the tube and apply a small amount to the hands sufficient for the area to be treated.Apply the cream in a thin layer, massaging it in.
Wash hands thoroughly and tightly close the tube after use.
If you use more Suniderma cream than you should
If you apply more than the recommended amount ofSunidermacream (repeated overdoses), you may experience side effects (see section4).
If you use the cream more frequently than you should or on large areas of the skin, it may be absorbed into the body and cause various disorders.
In cases of chronic toxicity, corticosteroids should be withdrawn gradually. The treatment of overdose is symptomatic. Acute symptoms of excessive corticosteroid use are generally reversible.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately, or go to a medical center, or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forgot to use Suniderma cream
Do not apply a double dose to compensate for the missed dose.
If you forgot to apply the cream, apply the corresponding dose when you remember, and continue treatment as usual.
If you interrupt treatment with Suniderma cream
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
The use of corticosteroids for prolonged periods and/or in extensive areas or with dressings or occlusive materials can produce adverse effects not only in the application area but also in other areas of the body.
Adverse effects that can occur:
- Skin atrophy (thinning of the skin thickness)
- Striae in the skin
- Skin fragility
- Acne
- Dilations of small superficial blood vessels under the skin (telangiectasias)
- Inflammation of hair follicles (folliculitis)
- Increased hair growth (hypertrichosis)
- Change in skin color
- Hypersensitivity reaction such as contact allergic dermatitis
- Easy bruising (ecchymoses)
- Redness/irritation
- Secondary infection, including fungal infections
- Appearance of certain red grains around the mouth (perioral dermatitis) or on the rest of the face (rosacea).
- Blurred vision (frequency "unknown").
Adverse effects that affect other parts of the body are:
Itmay cause a condition characterized by a rounded face, obesity, accumulation of fat in the cervical area (Cushing's syndrome), delayed healing (such as leg wounds and ulcers), glaucoma, cataracts, etc.
Withdrawal reaction to steroids:
If you use this medication continuously for prolonged periods, you may experience a withdrawal reaction when stopping treatment with some of the following symptoms: redness of the skin that may extend beyond the initially treated area, burning or stinging sensation, intense itching, skin peeling, open sores that suppurate.
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use:https://www.notificaRAM.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Do not store at a temperature above25ºC.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be thrown down the drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection pointof the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Suniderma cream
- The active ingredient is hydrocortisone aceponate. Each g of cream contains 1.27 mg of hydrocortisone aceponate (0.127%).
- The other components are: emulsifying wax, petrolatum, stearic alcohol, benzyl alcohol, and purified water.
Appearance of the product and contents of the packaging
Suniderma is a white cream.
It is presented in tubes containing 30 g and 60 g.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization:
Laboratoires Bailleul, S.A.
14-16 Avenue Pasteur
L-2310 Luxembourg
LUXEMBOURG
Responsible for manufacturing:
Lichtenheldt GmbH Pharmaceutical Factory
Lichtenheldt GmbH – Werk I
Industriestrasse 7 – 11
23812 Wahlstedt
(Germany)
Last review date of this leaflet: August 2023
The detailed and updated information on this medication is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS) http://www.aemps.es
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.